Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

[Agitation and acute psychosis].

Verdoux H.

Rev Prat. 2018 Jun;68(6):e243-e248. French. No abstract available.

PMID:
30869273
2.

Multi-trajectories of antidepressant and antipsychotic use: a 11-year naturalistic study in a community-based sample.

Verdoux H, Pambrun E, Tournier M, Cortaredona S, Verger P.

Acta Psychiatr Scand. 2019 Mar 7. doi: 10.1111/acps.13020. [Epub ahead of print]

PMID:
30844084
3.

GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.

Carrier H, Zaytseva A, Bocquier A, Villani P, Verdoux H, Fortin M, Verger P.

Br J Gen Pract. 2019 Feb 25. pii: bjgp19X701801. doi: 10.3399/bjgp19X701801. [Epub ahead of print]

PMID:
30803978
4.

Satisfaction and Needs in Serious Mental Illness and Autism Spectrum Disorder: The REHABase Psychosocial Rehabilitation Project.

Franck N, Bon L, Dekerle M, Plasse J, Massoubre C, Pommier R, Legros-Lafarge E, Jaafari N, Guillard-Bouhet N, Quilès C, Couhet G, Verdoux H, Gouache B, Martin B, Cervello S, Demily C, Dubreucq J.

Psychiatr Serv. 2019 Jan 29:appips201800420. doi: 10.1176/appi.ps.201800420. [Epub ahead of print]

PMID:
30691384
5.

[Use and misuse of benzodiazepines in patients with psychiatric disorders].

Panes A, Fourrier-Réglat A, Verdoux H, Tournier M.

Presse Med. 2018 Oct;47(10):886-891. doi: 10.1016/j.lpm.2018.10.003. Epub 2018 Oct 25. Review. French.

PMID:
30454581
6.

Trajectories of Antipsychotic Drug Use Over 10 Years in a French Community-Based Sample of Persons Aged 50 and Older.

Verdoux H, Pambrun E, Tournier M, Cortaredona S, Verger P.

Am J Geriatr Psychiatry. 2019 Jan;27(1):73-83. doi: 10.1016/j.jagp.2018.09.005. Epub 2018 Sep 14.

PMID:
30442530
7.

Psychotic Experiences and Related Distress: A Cross-national Comparison and Network Analysis Based on 7141 Participants From 13 Countries.

Wüsten C, Schlier B, Jaya ES; Genetic Risk and Outcome of Psychosis (GROUP) Investigators, Fonseca-Pedrero E, Peters E, Verdoux H, Woodward TS, Ziermans TB, Lincoln TM.

Schizophr Bull. 2018 Oct 17;44(6):1185-1194. doi: 10.1093/schbul/sby087.

PMID:
29982814
8.

Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.

Billioti de Gage S, Collin C, Le-Tri T, Pariente A, Bégaud B, Verdoux H, Dray-Spira R, Zureik M.

CNS Drugs. 2018 Jul;32(7):673-684. doi: 10.1007/s40263-018-0537-1.

9.

Prescriber and institutional barriers and facilitators of clozapine use: A systematic review.

Verdoux H, Quiles C, Bachmann CJ, Siskind D.

Schizophr Res. 2018 Nov;201:10-19. doi: 10.1016/j.schres.2018.05.046. Epub 2018 Jun 4. Review.

PMID:
29880453
10.

Safety of psychotropic medicines: contribution from observational evidence.

Verdoux H.

Epidemiol Psychiatr Sci. 2018 Dec;27(6):531-536. doi: 10.1017/S2045796018000276. Epub 2018 May 30.

PMID:
29843842
11.

[Computer-assisted therapy and video games in psychosocial rehabilitation for schizophrenia patients].

Brun G, Verdoux H, Couhet G, Quiles C.

Encephale. 2018 Sep;44(4):363-371. doi: 10.1016/j.encep.2017.12.009. Epub 2018 Mar 1. Review. French.

PMID:
29501256
12.

Trajectory analysis of anxiolytic dispensing over 10 years among new users aged 50 and older.

Verger P, Mmadi Mrenda B, Cortaredona S, Tournier M, Verdoux H.

Acta Psychiatr Scand. 2018 Apr;137(4):328-341. doi: 10.1111/acps.12858. Epub 2018 Feb 13.

PMID:
29441519
13.

The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs.

Nordon C, Battin C, Verdoux H, Haro JM, Belger M, Abenhaim L, van Staa TP.

Clin Epidemiol. 2017 Dec 14;9:689-698. doi: 10.2147/CLEP.S145353. eCollection 2017.

14.

Eight-Year Follow-up of Hypnotic Delivery by Adults Aged 50 and Older from an Insurance Database.

Verger P, Cortaredona S, Jacqmin-Gadda H, Tournier M, Verdoux H.

Sleep. 2017 Nov 1;40(11). doi: 10.1093/sleep/zsx147.

PMID:
28958019
15.

International trends in antipsychotic use: A study in 16 countries, 2005-2014.

Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté AC, Furu K, Garuoliené K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Skurtveit S, Verdoux H, Wang LJ, Yahni CZ, Bachmann CJ.

Eur Neuropsychopharmacol. 2017 Oct;27(10):1064-1076. doi: 10.1016/j.euroneuro.2017.07.001. Epub 2017 Jul 27.

PMID:
28755801
16.

Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database.

Nordon C, Bovagnet T, Belger M, Jimenez J, Olivares R, Chevrou-Severac H, Verdoux H, Haro JM, Abenhaim L, Karcher H; IMI GetReal WP2 group.

Schizophr Res. 2018 Mar;193:146-153. doi: 10.1016/j.schres.2017.07.031. Epub 2017 Jul 13. Review.

PMID:
28712965
17.

[Impact of education program and clinical posting in psychiatry on medical students' stigmatizing attitudes towards psychiatry and psychiatric disorders].

Simon N, Verdoux H.

Encephale. 2018 Sep;44(4):329-336. doi: 10.1016/j.encep.2017.05.003. Epub 2017 Jun 9. French.

PMID:
28606624
18.

International trends in clozapine use: a study in 17 countries.

Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Coma Fusté A, Furu K, Garuoliené K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Siskind D, Skurtveit S, Verdoux H, Wang LJ, Zara Yahni C, Zoëga H, Taylor D.

Acta Psychiatr Scand. 2017 Jul;136(1):37-51. doi: 10.1111/acps.12742. Epub 2017 May 14.

PMID:
28502099
19.

Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.

Verdoux H, Pambrun E, Tournier M, Bezin J, Pariente A.

Acta Psychiatr Scand. 2017 May;135(5):429-438. doi: 10.1111/acps.12722. Epub 2017 Mar 23.

PMID:
28332704
20.

Impact of prenatal exposure to diethylstilbestrol (DES) on psychological outcome: a national survey of DES daughters and unexposed controls.

Verdoux H, Devouche E, Tournaire M, Levadou A.

Arch Womens Ment Health. 2017 Jun;20(3):389-395. doi: 10.1007/s00737-016-0711-8. Epub 2017 Jan 7.

PMID:
28064340
21.

Comparison of pharmacy-based and diagnosis-based comorbidity measures from medical administrative data.

Cortaredona S, Pambrun E, Verdoux H, Verger P.

Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):402-411. doi: 10.1002/pds.4146. Epub 2016 Dec 2.

PMID:
27910177
22.

Frequency and pattern of Internet use in patients with schizophrenia or bipolar disorders seeking medical information.

Baup H, Verdoux H.

Psychiatry Res. 2017 Jan;247:152-154. doi: 10.1016/j.psychres.2016.11.028. Epub 2016 Nov 23.

PMID:
27893996
23.

Maternal depressive symptoms and early childhood cognitive development: a meta-analysis.

Liu Y, Kaaya S, Chai J, McCoy DC, Surkan PJ, Black MM, Sutter-Dallay AL, Verdoux H, Smith-Fawzi MC.

Psychol Med. 2017 Mar;47(4):680-689. doi: 10.1017/S003329171600283X. Epub 2016 Nov 11. Review.

PMID:
27834159
24.

Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study.

Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, Bégaud B, Pariente A.

Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):162-169. doi: 10.1002/pds.4123. Epub 2016 Nov 3.

PMID:
27807907
25.

Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.

Verdoux H, Pambrun E, Tournier M, Bezin J, Pariente A.

Schizophr Res. 2016 Dec;178(1-3):58-63. doi: 10.1016/j.schres.2016.09.014. Epub 2016 Sep 10.

PMID:
27624680
26.

Psychotropic drug dispensing in people with and without cancer in France.

Verger P, Cortaredona S, Tournier M, Rey D, Bendiane MK, Peretti-Watel P, Verdoux H.

J Cancer Surviv. 2017 Feb;11(1):92-101. doi: 10.1007/s11764-016-0569-9. Epub 2016 Aug 23.

PMID:
27553640
27.

Trends in patterns of antidepressant use in older general population between 2006 and 2012 following publication of practice guidelines.

Etchepare F, Pambrun E, Verdoux H, Tournier M.

Int J Geriatr Psychiatry. 2017 Aug;32(8):849-859. doi: 10.1002/gps.4536. Epub 2016 Jun 30.

PMID:
27357262
28.

Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users.

Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, Bégaud B, Pariente A.

Eur J Clin Pharmacol. 2016 Jul;72(7):869-76. doi: 10.1007/s00228-016-2044-y. Epub 2016 Mar 29.

PMID:
27023467
29.

Geographical disparities in prescription practices of lithium and clozapine: a community-based study.

Verdoux H, Pambrun E, Cortaredona S, Coldefy M, Le Neindre C, Tournier M, Verger P.

Acta Psychiatr Scand. 2016 Jun;133(6):470-80. doi: 10.1111/acps.12554. Epub 2016 Jan 30.

PMID:
26826542
30.

Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients.

Etchepare F, Pambrun E, Bégaud B, Verdoux H, Tournier M.

Fundam Clin Pharmacol. 2016 Feb;30(1):82-92. doi: 10.1111/fcp.12167. Epub 2015 Dec 16.

PMID:
26555674
31.

Associations between self-esteem, anxiety and depression and metacognitive awareness or metacognitive knowledge.

Quiles C, Prouteau A, Verdoux H.

Psychiatry Res. 2015 Dec 15;230(2):738-41. doi: 10.1016/j.psychres.2015.10.035. Epub 2015 Oct 31.

PMID:
26548980
32.

[Early prenatal interview and antenatal education for childbirth and parenthood: Associated psychosocial and obstetric characteristics in women of the ELFE cohort].

Barandon S, Balès M, Melchior M, Glangeaud-Freudenthal N, Pambrun E, Bois C, Verdoux H, Sutter-Dallay AL.

J Gynecol Obstet Biol Reprod (Paris). 2016 Jun;45(6):599-607. doi: 10.1016/j.jgyn.2015.06.026. Epub 2015 Aug 28. French.

33.

[Involuntary hospitalization under the Act of July 5th 2011: A study of patients' experience and understanding of their hearing with the judge ruling on civil detention cases].

Rossini K, Verdoux H.

Encephale. 2015 Sep;41(4):332-8. doi: 10.1016/j.encep.2015.03.005. Epub 2015 May 19. French.

PMID:
25998989
34.

Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses.

Sutter-Dallay AL, Bales M, Pambrun E, Glangeaud-Freudenthal NM, Wisner KL, Verdoux H.

J Clin Psychiatry. 2015 Jul;76(7):967-73. doi: 10.4088/JCP.14m09070.

PMID:
25844580
35.

Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.

Verdoux H, Pambrun E, Cortaredona S, Tournier M, Verger P.

Eur Child Adolesc Psychiatry. 2015 Oct;24(10):1181-91. doi: 10.1007/s00787-014-0668-y. Epub 2015 Jan 7.

PMID:
25564132
36.

Prenatal psychological distress and access to mental health care in the ELFE cohort.

Bales M, Pambrun E, Melchior M, Glangeaud-Freudenthal NM, Charles MA, Verdoux H, Sutter-Dallay AL.

Eur Psychiatry. 2015 Feb;30(2):322-8. doi: 10.1016/j.eurpsy.2014.11.004. Epub 2014 Dec 24.

PMID:
25542278
37.

Neurocognitive insight and executive functioning in schizophrenia.

Prouteau A, Atzeni T, Tastet H, Bergua V, Destaillats JM, Verdoux H.

Cogn Neuropsychiatry. 2015;20(1):64-71. doi: 10.1080/13546805.2014.973486. Epub 2014 Oct 31.

PMID:
25359274
38.

Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample.

Verdoux H, Pambrun E.

Acta Psychiatr Scand. 2014 Dec;130(6):487-97. doi: 10.1111/acps.12344. Epub 2014 Oct 10.

PMID:
25302631
39.

Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Bégaud B.

BMJ. 2014 Sep 9;349:g5205. doi: 10.1136/bmj.g5205.

40.

Assessing metacognition during a cognitive task: impact of "on-line" metacognitive questions on neuropsychological performances in a non-clinical sample.

Quiles C, Verdoux H, Prouteau A.

J Int Neuropsychol Soc. 2014 May;20(5):547-54. doi: 10.1017/S1355617714000290.

PMID:
24867441
41.

Social inequalities in early antidepressant discontinuation.

Bocquier A, Cortaredona S, Verdoux H, Casanova L, Sciortino V, Nauleau S, Verger P.

Psychiatr Serv. 2014 May 1;65(5):618-25. doi: 10.1176/appi.ps.201300184.

PMID:
24487546
42.

Antidepressant treatment patterns in younger and older adults from the general population in a real-life setting.

Etchepare F, Sanglier T, André M, Verdoux H, Tournier M.

Int J Geriatr Psychiatry. 2014 Sep;29(9):928-35. doi: 10.1002/gps.4081. Epub 2014 Jan 29.

PMID:
24477963
43.

Physicians' characteristics associated with exploring suicide risk among patients with depression: a French panel survey of general practitioners.

Bocquier A, Pambrun E, Dumesnil H, Villani P, Verdoux H, Verger P.

PLoS One. 2013 Dec 10;8(12):e80797. doi: 10.1371/journal.pone.0080797. eCollection 2013.

44.

Psychotherapy for depression in primary care: a panel survey of general practitioners' opinion and prescribing practice.

Verdoux H, Cortaredona S, Dumesnil H, Sebbah R, Verger P.

Soc Psychiatry Psychiatr Epidemiol. 2014 Jan;49(1):59-68. doi: 10.1007/s00127-013-0717-8. Epub 2013 Jun 16.

PMID:
23771250
45.
46.

Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial.

Franck N, Duboc C, Sundby C, Amado I, Wykes T, Demily C, Launay C, Le Roy V, Bloch P, Willard D, Todd A, Petitjean F, Foullu S, Briant P, Grillon ML, Deppen P, Verdoux H, Bralet MC, Januel D, Riche B, Roy P; Other members of the Cognitive Remediation Network, Vianin P.

Schizophr Res. 2013 Jun;147(1):68-74. doi: 10.1016/j.schres.2013.03.009. Epub 2013 Apr 9.

PMID:
23583327
47.

Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort.

Resseguier N, Verdoux H, Giorgi R, Clavel-Chapelon F, Paoletti X.

BMC Med Res Methodol. 2013 Feb 21;13:28. doi: 10.1186/1471-2288-13-28.

48.

Social inequalities in new antidepressant treatment: a study at the individual and neighborhood levels.

Bocquier A, Cortaredona S, Verdoux H, Sciortino V, Nauleau S, Verger P.

Ann Epidemiol. 2013 Mar;23(3):99-105. doi: 10.1016/j.annepidem.2012.12.008. Epub 2013 Jan 10.

PMID:
23313265
49.

General practitioners' choices and their determinants when starting treatment for major depression: a cross sectional, randomized case-vignette survey.

Dumesnil H, Cortaredona S, Verdoux H, Sebbah R, Paraponaris A, Verger P.

PLoS One. 2012;7(12):e52429. doi: 10.1371/journal.pone.0052429. Epub 2012 Dec 18.

50.

[Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].

Verdoux H, Gaudron Y, Auleley GR, Deligne J, Blum-Boisgard C, Thiébaut A, Tournier M.

Encephale. 2013 May;39 Suppl 1:S22-8. doi: 10.1016/j.encep.2012.10.009. Epub 2012 Dec 13. French.

PMID:
23246328

Supplemental Content

Loading ...
Support Center